X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
frax (512) 512
osteoporosis (456) 456
index medicus (395) 395
humans (368) 368
fractures (311) 311
female (294) 294
endocrinology & metabolism (292) 292
risk factors (284) 284
aged (269) 269
middle aged (244) 244
orthopedics (214) 214
risk assessment (214) 214
medicine & public health (203) 203
postmenopausal women (193) 193
endocrinology (183) 183
male (181) 181
bone density (179) 179
women (168) 168
aged, 80 and over (161) 161
bone mineral density (153) 153
rheumatology (147) 147
men (146) 146
hip fracture (142) 142
risk assessment - methods (140) 140
bone-mineral density (139) 139
osteoporotic fractures - epidemiology (135) 135
fracture risk (125) 125
algorithms (121) 121
diagnosis (117) 117
fracture (108) 108
osteoporotic fractures (98) 98
risk (98) 98
density (96) 96
hip (94) 94
epidemiology (93) 93
hip fractures - epidemiology (89) 89
bones (88) 88
management (86) 86
osteoporotic fractures - etiology (86) 86
bmd (83) 83
research (83) 83
bone density - physiology (76) 76
health risk assessment (75) 75
absorptiometry, photon (73) 73
care and treatment (71) 71
prediction (70) 70
adult (69) 69
probability (69) 69
bone density conservation agents - therapeutic use (63) 63
osteoporotic fractures - prevention & control (62) 62
prevalence (59) 59
osteoporotic fractures - physiopathology (58) 58
health aspects (57) 57
osteoporosis - epidemiology (56) 56
prevention (56) 56
usage (54) 54
incidence (52) 52
analysis (51) 51
hip fractures - etiology (49) 49
vertebral fractures (49) 49
gynecology (48) 48
age (47) 47
article (47) 47
osteoporosis - diagnosis (47) 47
osteoporosis - drug therapy (47) 47
osteoporotic fracture (47) 47
osteoporotic fractures - diagnosis (45) 45
validation (45) 45
bone (44) 44
intervention thresholds (43) 43
cross-sectional studies (41) 41
fractures, bone - epidemiology (41) 41
osteoporosis - complications (41) 41
complications and side effects (40) 40
age factors (39) 39
guidelines (39) 39
medicine, general & internal (39) 39
fractures, bone - etiology (38) 38
metaanalysis (38) 38
osteoporosis, postmenopausal - epidemiology (38) 38
cohort studies (37) 37
osteoporosis, postmenopausal - complications (37) 37
femur neck - physiopathology (36) 36
population (36) 36
mineral density (35) 35
mortality (35) 35
vertebral fracture (34) 34
internal medicine (33) 33
osteoporosis - physiopathology (33) 33
fracture probability (32) 32
models (32) 32
hip joint (31) 31
methods (31) 31
osteopenia (31) 31
absorptiometry, photon - methods (30) 30
cohort (30) 30
hip fractures - physiopathology (30) 30
body mass index (29) 29
dual energy x-ray absorptiometry (29) 29
femur (29) 29
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (529) 529
Spanish (13) 13
French (5) 5
German (5) 5
Polish (4) 4
Portuguese (2) 2
Russian (2) 2
Czech (1) 1
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


OSTEOPOROSIS INTERNATIONAL, ISSN 0937-941X, 06/2010, Volume 21, pp. 407 - 413
This paper reviews briefly the development and clinical use of FRAXA (R) in the development of assessment guidelines for osteoporosis. Fractures are the... 
DIAGNOSIS | Fracture probability | FRAX | MANAGEMENT | ABSOLUTE FRACTURE RISK | GUIDELINES | HIP | POSTMENOPAUSAL OSTEOPOROSIS | Case finding | MASS | ENDOCRINOLOGY & METABOLISM | Clinical guidelines | BMD | Intervention threshold | PROBABILITIES
Journal Article
OSTEOPOROSIS INTERNATIONAL, ISSN 0937-941X, 03/2010, Volume 21, Issue 3, pp. 381 - 389
A Swiss-specific FRAXA (R) model was developed. Patient profiles at increased probability of fracture beyond currently accepted reimbursement thresholds for... 
FRAX (R) | DIAGNOSIS | BONE-MINERAL DENSITY | CROHNS-DISEASE | ULCERATIVE-COLITIS | Osteoporotic fracture | 10-year fracture probability | Hip fracture | VERTEBRAL FRACTURES | MEN | ENDOCRINOLOGY & METABOLISM | QUANTITATIVE ULTRASOUND | Clinical risk factors | POSTMENOPAUSAL WOMEN | RISK-ASSESSMENT
Journal Article
OSTEOPOROSIS INTERNATIONAL, ISSN 0937-941X, 03/2011, Volume 22, Issue 3, pp. 829 - 837
A new Canadian WHO fracture risk assessment (FRAXA (R)) tool to predict 10-year fracture probability was compared with observed 10-year fracture outcomes in a... 
FRAX | METAANALYSIS | BONE-MINERAL DENSITY | Fracture | PREVALENCE | Canada | Osteoporosis | HIP FRACTURE | WOMEN | Fracture prediction | MEN | ENDOCRINOLOGY & METABOLISM | OSTEOPOROTIC FRACTURES | BMD | QUALITY-OF-LIFE | CLINICAL RISK-FACTORS
Journal Article
OSTEOPOROSIS INTERNATIONAL, ISSN 0937-941X, 01/2010, Volume 21, Issue 1, pp. 25 - 33
On the basis of updated fracture and mortality data, we recommend that the base population values used in the US version of FRAXA (R) be revised. The impact of... 
UNITED-STATES | FRAX (R) | VITAMIN-D | BONE-MINERAL DENSITY | Fracture | PREVENT FRACTURES | HIP | VERTEBRAL FRACTURES | Risk assessment | CALCIUM | ENDOCRINOLOGY & METABOLISM | OSTEOPOROTIC FRACTURES | POSTMENOPAUSAL WOMEN | RISK-ASSESSMENT
Journal Article
OSTEOPOROSIS INTERNATIONAL, ISSN 0937-941X, 04/2010, Volume 21, Issue 4, pp. 537 - 541
Journal Article
Osteoporosis International, ISSN 0937-941X, 10/2008, Volume 19, Issue 10, pp. 1395 - 1408
Assessment and intervention thresholds are developed and proposed in men aged over 50 years and postmenopausal women for the UK based on fracture probability... 
Fracture probability | FRAX | Medicine & Public Health | Gynecology | Orthopedics | Assessment thresholds | Rheumatology | BMD | Clinical risk factors | Intervention thresholds | Osteoporotic fracture | Endocrinology | FRAX (R) | COST-EFFECTIVENESS | BONE-MINERAL DENSITY | fracture probability | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | ELDERLY-WOMEN | osteoporotic fracture | ALENDRONATE | intervention thresholds | POSTMENOPAUSAL OSTEOPOROSIS | ECONOMIC-EVALUATION | VERTEBRAL FRACTURE RISK | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | assessment thresholds | clinical risk factors | RISEDRONATE | Osteoporosis, Postmenopausal - epidemiology | Risk Assessment - methods | Age Factors | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Fractures, Bone - epidemiology | Male | Osteoporosis - drug therapy | Patient Selection | Fractures, Bone - etiology | Aged, 80 and over | Female | Osteoporosis - epidemiology | Bone Density | Decision Support Techniques | Bone Density Conservation Agents - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - economics | Algorithms | Cost-Benefit Analysis | Osteoporosis - complications | Femur Neck - physiopathology | Aged | United Kingdom - epidemiology | Fractures, Bone - prevention & control | Osteoporosis | Bones | Bone density | Fractures | Health risk assessment | Postmenopausal | methods | 80 and over | epidemiology | Great Britain | Endokrinologi och diabetes | Bone Density Conservation Agents | Physiology | Endocrinology and Diabetes | drug therapy | complications | Risk Assessment | Fysiologi | Femur Neck | prevention & control | etiology | economics | physiopathology | Bone | therapeutic use
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 01/2018, Volume 20, Issue 1, pp. 16 - 10
Background: Positive anticyclic citrullinated peptide (anti-CCP+) is associated with bone loss in patients with rheumatoid arthritis (RA). However, whether... 
Anti-cyclic citrullinated peptide | FRAX | Rheumatoid arthritis | PROTEIN ANTIBODIES | LONG-TERM | BONE-MINERAL DENSITY | CYCLIC CITRULLINATED PEPTIDE | RISK | CLASSIFICATION | RHEUMATOLOGY | RHEUMATOID-ARTHRITIS PATIENTS | WOMEN | GENERAL-POPULATION | SERUM-LEVELS | Development and progression | Care and treatment | Genetic aspects | Fractures | Peptides | Health aspects
Journal Article
Osteoporosis International, ISSN 0937-941X, 1/2012, Volume 23, Issue 1, pp. 391 - 397
Journal Article
Journal Article
OSTEOPOROSIS INTERNATIONAL, ISSN 0937-941X, 06/2015, Volume 26, Issue 6, pp. 1841 - 1848
ASummary FRAXA (R) is widely used to evaluate fracture risk of individuals in clinical settings. However, FRAXA (R) prediction accuracy is not sufficient, and... 
FRAX (R) | POPULATION | Reclassification improvement | TBS | Fracture risk assessment | CAUCASIAN WOMEN | JPOS COHORT | HIP | MINERAL DENSITY | Trabecular bone score | VERTEBRAL FRACTURES | LUMBAR SPINE | ENDOCRINOLOGY & METABOLISM | Elderly Japanesemen | SELF-REPORT | POSTMENOPAUSAL WOMEN
Journal Article
BONE, ISSN 8756-3282, 10/2010, Volume 47, Issue 4, pp. 729 - 735
Introduction: Multiple Outcomes of Raloxifene Evaluation (MORE), a placebo controlled phase III study of raloxifene in postmenopausal osteoporosis, showed that... 
Fracture probability | FRAX | PLACEBO | RISK-FACTORS | BONE-MINERAL DENSITY | PREVALENT | TRIAL | PROBABILITY | Clinical fracture | MORE study | ENDOCRINOLOGY & METABOLISM | Vertebral fracture | OSTEOPOROTIC FRACTURES | MULTIPLE OUTCOMES | DOUBLE-BLIND | Raloxifene | POSTMENOPAUSAL WOMEN
Journal Article
OSTEOPOROSIS INTERNATIONAL, ISSN 0937-941X, 05/2018, Volume 29, Issue 5, pp. 1105 - 1115
We assessed the FRAXA (R) method in 718 hemodialyzed patients in estimating increased risk of bone major and hip fractures. Over two prospective years,... 
FRAX (R) | RISK-FACTORS | DENOSUMAB | Chronic kidney disease | PREVALENCE | Falls | HIP FRACTURE | MINERAL DENSITY | VERTEBRAL FRACTURES | Bone fracture | ENDOCRINOLOGY & METABOLISM | Dialysis | EPIDEMIOLOGY
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 02/2019, Volume 95, Issue 2, pp. 447 - 454
The Fracture Risk Assessment Tool (FRAX®) was developed to predict fracture risk in the general population, but its applicability to patients with chronic... 
bone mineral density | chronic kidney disease | fracture discrimination | FRAX | fracture | MORTALITY | BONE-MINERAL DENSITY | RENAL-FUNCTION | PREVALENCE | HIP FRACTURE | WOMEN | OSTEOPOROTIC FRACTURES | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | ASSOCIATION | BURDEN
Journal Article